VANGUARD GROUP INC - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 187 filers reported holding MYRIAD GENETICS INC in Q1 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q3 2023$147,002,382
-30.7%
9,164,737
+0.1%
0.00%
-20.0%
Q2 2023$212,151,404
-1.8%
9,152,347
-1.6%
0.01%0.0%
Q1 2023$216,002,158
+59.9%
9,298,414
-0.1%
0.01%
+25.0%
Q4 2022$135,113,652
-22.4%
9,311,761
+2.0%
0.00%
-20.0%
Q3 2022$174,170,000
+6.4%
9,128,384
+1.4%
0.01%0.0%
Q2 2022$163,651,000
-27.7%
9,006,680
+0.3%
0.01%0.0%
Q1 2022$226,211,000
-10.4%
8,976,593
-1.9%
0.01%
-16.7%
Q4 2021$252,527,000
-13.4%
9,149,521
+1.3%
0.01%
-14.3%
Q3 2021$291,681,000
+6.6%
9,033,197
+0.9%
0.01%0.0%
Q2 2021$273,716,000
+4.2%
8,950,820
+3.8%
0.01%0.0%
Q1 2021$262,621,000
+60.1%
8,624,665
+4.0%
0.01%
+40.0%
Q4 2020$164,070,000
+57.3%
8,296,864
+3.7%
0.01%
+66.7%
Q3 2020$104,295,000
+11.5%
7,998,018
-3.0%
0.00%0.0%
Q2 2020$93,514,000
-21.9%
8,246,412
-1.4%
0.00%
-40.0%
Q1 2020$119,710,000
-47.2%
8,365,447
+0.5%
0.01%
-37.5%
Q4 2019$226,569,000
-8.5%
8,320,574
-3.8%
0.01%
-11.1%
Q3 2019$247,655,000
+7.1%
8,650,251
+3.9%
0.01%0.0%
Q2 2019$231,234,000
-18.4%
8,323,769
-2.5%
0.01%
-18.2%
Q1 2019$283,471,000
+6.1%
8,538,277
-7.1%
0.01%
-8.3%
Q4 2018$267,233,000
-32.9%
9,192,715
+6.2%
0.01%
-25.0%
Q3 2018$398,219,000
+28.5%
8,656,933
+4.4%
0.02%
+23.1%
Q2 2018$309,843,000
+34.9%
8,291,236
+6.6%
0.01%
+30.0%
Q1 2018$229,742,000
-7.4%
7,774,668
+7.6%
0.01%
-9.1%
Q4 2017$248,118,000
+8.4%
7,224,302
+14.2%
0.01%0.0%
Q3 2017$228,930,000
+40.5%
6,327,512
+0.3%
0.01%
+37.5%
Q2 2017$162,992,000
+35.8%
6,307,738
+0.9%
0.01%
+33.3%
Q1 2017$120,020,000
+34.5%
6,251,030
+16.8%
0.01%
+20.0%
Q4 2016$89,248,000
-16.5%
5,353,743
+3.1%
0.01%
-16.7%
Q3 2016$106,918,000
-32.8%
5,195,212
-0.0%
0.01%
-40.0%
Q2 2016$159,018,000
-16.3%
5,196,666
+2.4%
0.01%
-16.7%
Q1 2016$189,956,000
-9.3%
5,074,985
+4.6%
0.01%
-14.3%
Q4 2015$209,484,000
+19.4%
4,853,649
+3.7%
0.01%
+100.0%
Q3 2015$175,415,000
+10.1%
4,680,243
-0.2%
0.01%
-36.4%
Q2 2015$159,335,000
-5.2%
4,687,675
-1.3%
0.01%0.0%
Q1 2015$168,080,000
+3.8%
4,748,029
-0.1%
0.01%
-8.3%
Q4 2014$161,875,000
-12.5%
4,752,636
-1.0%
0.01%
-14.3%
Q3 2014$185,077,000
-5.8%
4,798,467
-5.0%
0.01%
-6.7%
Q2 2014$196,572,000
+18.0%
5,050,663
+3.7%
0.02%
+7.1%
Q1 2014$166,526,000
+62.5%
4,870,590
-0.3%
0.01%
+55.6%
Q4 2013$102,495,000
-9.9%
4,885,391
+0.9%
0.01%
-18.2%
Q3 2013$113,740,000
-3.8%
4,839,989
+10.0%
0.01%
-8.3%
Q2 2013$118,230,0004,400,0970.01%
Other shareholders
MYRIAD GENETICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
SCOPIA CAPITAL MANAGEMENT LP 6,459,139$278,776,0005.53%
Tieton Capital Management, LLC 119,290$5,149,0004.04%
RPg Family Wealth Advisory, LLC 97,202$4,195,238,0003.85%
RK Capital 384,900$16,612,0002.90%
Contrarius Investment Management Ltd 652,288$28,153,0002.65%
S&T BANK/PA 331,885$14,324,0002.22%
Euclidean Technologies Management, LLC 40,917$1,766,0001.90%
AIMZ Investment Advisors, LLC 45,635$1,970,0001.80%
Taylor Frigon Capital Management LLC 34,783$1,486,0001.67%
KILLEN GROUP INC 366,305$15,810,0001.63%
View complete list of MYRIAD GENETICS INC shareholders